David L. Vaux - Concepedia

Author

David L. Vaux

Walter and Eliza Hall Institute of Medical Research ORCID

Also Known As

D L Vaux, D VAUX, D Vaux, D. L Vaux, D. L. Vaux, D. Vaux, D.L Vaux, D.L. Vaux, DAVID L VAUX, DAVID L. VAUX

272

Publications

33.1K

Citations

H-Index

152

Concepts

All Affiliations

Walter and Eliza Hall Institute of Medical Research La Trobe University The University of Melbourne The Royal Melbourne Hospital Murdoch Children's Research Institute

About

David L. Vaux is an author at Walter and Eliza Hall Institute of Medical Research specializing in medicine, cell biology, and cell death.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	57	15.8K
2	Engineering	7	7	1.4K
3	Arts	2	2	32
4	Education	1	1	49
5	Health Sciences	1	1	180

David L. Vaux

107

Publications

23.1K

Citations

H-Index

Page 1

	Year	Citations
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells David L. Vaux, Suzanne Cory, Jerry M. Adams Nature Hematological MalignancyHematologyImmunologyCell DeathPre-b Cells	1988	3.2K
Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins Anne M. Verhagen, Paul G. Ekert, Miha Pakusch, Cell Protein FunctionAutoimmune DiseaseApoptosisImmunologyCell Death	2000	2.3K
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis James E. Vince, W. Wei‐Lynn Wong, Nufail Khan, Cell Signal TransductionSignaling PathwayMedicineApoptosisImmunology	2007	1.1K
Error bars in experimental biology Geoff Cumming, Fiona Fidler, David L. Vaux The Journal of Cell Biology BiologyReliabilityEffective UseError AnalysisEngineering	2007	895
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Andreas Strasser, Senga Whittingham, David L. Vaux, Proceedings of the National Academy of Sciences Humoral ResponseImmunologyImmunologic MechanismImmunotherapyImmunogenetics	1991	867
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death Guido Kroemer, Wafik S. El‐Deiry, Pierre Golstein, Cell Death and Differentiation Nomenclature CommitteeMedicineApoptosisHistopathologyPathology	2005	824
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL Kate E. Lawlor, Nufail Khan, Alison Mildenhall, Nature Communications	2015	624
Prevention of Programmed Cell Death in <i>Caenorhabditis elegans</i> by Human <i>bcl-2</i> David L. Vaux, Irving L. Weissman, Stuart K. Kim Science Signal TransductionCell RegulationMedicineApoptosisGene Expression	1992	623
RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis James A. Rickard, Joanne A. O’Donnell, Joseph M. Evans, Cell InflammationCytokineReceptor Tyrosine KinaseImmunologyHematology	2014	576
Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome Vanessa S. Marsden, Liam O’Connor, Lorraine A. O’Reilly, Nature MitophagyBcl-2-regulated Caspase ActivationSignal TransductionMedicineApoptosis	2002	560

Page 1